1 |
Kang, N. Y., S. K Kang, Y. C. Lee, H. J. Choi, Y. S. Lee,
S. Y. Cho, Y. S. Kim, J. H. Ko, and C. H. Kim. 2006.
Transcriptional regulation of the human GD3 synthase gene
expression in Fas-induced Jurkat T cells: a critical role of
transcription factor NF-B in regulated expression.
Glycobiology 16, 375-389.
DOI
|
2 |
Merritt, W. D., J. T. Casper, S. J. Lauer and G. H. Reaman.
1987. Expression of GD3 ganglioside in childhood T-cell
lymphoblastic malignancies. Cancer Res. 47, 1724-1730.
|
3 |
Old, L. J. 1981. Cancer immunology: the search for specificity-G. H. A. Clowes Memorial lecture. Cancer Res. 41,
361-375.
|
4 |
Pan, M., S. Geng, S. Xiao, J. Ren, Y. Liu, X. Li, Z. Li, and
Z. Peng. 2009. Apoptosis induced by synthetic retinoic acid
CD437 on human melanoma A375 cells involves RIG-I
pathway. Arch. Dermatol. Res. 301, 15-20.
DOI
|
5 |
Fukuda, M., K. Horibe, and K. Furukawa. 1998. Enhancement
of in vitro and in vivo anti-tumor activity of anti-GD2 monoclonal
antibody 220-51 against human neuroblastoma by
granulocyte-macrophage colony-stimulating factor and
granulocyte colony-stimulating factor. Int. J. Mol. Med. 2,
471-475.
|
6 |
Hakomori, S. 1996. Tumor malignancy defined by aberrant
glycosylation and sphingo (glyco) lipid metabolism. Cancer Res. 56, 5309-5318.
|
7 |
Hakomori, S. 1981.lycosphingolipids in cellular interaction,
differentiation, and oncogenesis. Annu. Rev. Biochem. 50,
733-764.
DOI
|
8 |
Haraguchi, M., S. Yamashiro, A. Yamamoto, K. Furukawa,
K. Takamiya, K. O. Lloyd, H. Shiku, and K. Furukawa. 1994.
Isolation of GD3 synthase gene by expression cloning of
GM3 -2,8-sialyltransferase cDNA using anti-GD2 monoclonal antibody. Proc. Natl. Acad. Sci. USA 91, 10455-10459.
DOI
|
9 |
Kang, N. Y., C. H. Kim, K. S. Kim, J. H. Ko, J. H. Lee,
Y. K. Jeong, and Y. C. Lee. 2007. Expression of the human
CMP-NeuAc:GM3 2,8 sialyltransferase (GD3 synthase)
gene through the NF-B activation in human melanoma
SK-MEL-2 cells. Biochim. Biophys. Acta 1769, 622-630.
DOI
ScienceOn
|
10 |
Baeuerle, P. A. and D. Baltimore. 1996. NF-B: ten years
after. Cell 87, 13-20.
DOI
|
11 |
Chen, F., V. Castranova, and X. Shi. 2001. New insights into
the role of nuclear factor-B in cell growth regulation. Am. J. Pathol. 159, 387-397.
DOI
ScienceOn
|
12 |
Cheung, N. K., U. M. Saarinen, J. E. Neely, B. Landmeier,
D. Donovan, and P. F. Coccia. 1985. Monoclonal antibodies
to a glycolipid antigen on human neuroblastoma cells.
Cancer Res. 45, 2642-2649.
|
13 |
Dippold, W. G., K. O. Lloyd, L. T. Li, H. Ikeda, H. F.
Oettgen, and L. J. Old. 1980. Cell surface antigens of human
malignant melanoma: definition of six antigenic systems
with mouse monoclonal antibodies. Proc. Natl. Acad. Sci. USA, 77, 6114-6118.
DOI
|
14 |
Fields, A. L., D. R. Soprano, and K. J. Soprano. 2007.
Retinoids in biological control and cancer. J. Cell Biochem.
102, 886-898.
DOI
|
15 |
Sasaki, K., K. Kurata, N. Kojima, N. Kurosawa, S. Ohta, N.
Hanai, S. Tsuji, and T. Nishi. 1994. Expression cloning of
a GM3-specific -2,8-sialyltransferase (GD3 synthase). J. Biol. Chem. 269, 15950-15956.
|
16 |
Fligiel, S. E., D. R. Inman, H. S. Talwar, G. J. Fisher, J. J.
Voorhees, and J. Varani. 1992. Modulation of growth in normal
and malignant melanocytic cells by all-trans retinoic acid. J. Cutan Pathol. 19, 27-33.
DOI
|
17 |
Zhang, H., S. Zhang, N.-K. V. Cheung, G. Ragupathi, and
P. O. Livingston. 1998. Antibodies against GD2 ganglioside
can eradicate syngeneic cancer micrometastases. Cancer Res.
58, 2844-2849.
|
18 |
Welte, K., G. Miller, P. B. Chapman, H. Yuasa, E. Natoli,
J. E. Kunicka, C. Cordon-Cardo, C. Buhrer, L. J. Old, and
A. N. Houghton. 1987. Stimulation of T lymphocyte proliferation
by monoclonal antibodies against GD3 ganglioside.
J. Immunol. 139, 1763-1771.
|
19 |
Yamaguchi, H., K. Furukawa, S. R. Fortunato, P. O. Livingston, K. O. Lloyd, H. F. Oettgen, and L. J. Old. 1987.
Cell-surface antigens of melanoma recognized by human
monoclonal antibodies. Proc. Natl. Acad. Sci. USA 84,
2416-2420.
DOI
|
20 |
Yamashiro, S., M. Okada, M. Haraguchi, K. Furukawa, K.
O. Lloyd, H. Shiku, and K. Furukawa. 1995. Expression of
2,8-sialyltransferase (GD3 synthase) gene in human cancer cell lines: high level expression in melanomas and up-regulation
in activated T lymphocytes. Glycoconj. J. 12, 894-900.
DOI
|
21 |
Sporn, M. B. and A. B. Roberts. 1983. Role of retinoids in differentiation and carcinogenesis, Cancer Res. 43, 3034-3040.
|
22 |
Svennerholm, L. 1980. Gangliosides and synaptic transmission.
Adv. Exp. Med. Biol. 125, 533-544.
DOI
|
23 |
Thampoe, I. J., K. Furukawa, E. Vellvé, and K. O. Lloyd.
1989. Sialyltransferase levels and ganglioside expression in
melanoma and other cultured human cancer cells. Cancer Res. 49, 6258-6264.
|
24 |
Rusan, S., B. K. Raj, and K. O. Lloyd. 1999. Relationship
of glycosyltransferases and mRNA levels to ganglioside expression
in neuroblastoma and melanoma cells. J. Neurochem.
72, 514-521.
DOI
|
25 |
Portoukalian, J., G. Zwingelstein, and J. F. Dore. 1979. Lipid
composition of human malignant melanoma tumors at various
levels of malignant growth. Eur. J. Biochem. 94, 19-23.
DOI
|
26 |
Pukel, C. S., K. O. Lloyd, L. R. Travassos, W. G. Dippold,
H. F. Oettgen, and L. J. Old. 1982. GD3, a prominent ganglioside
of human melanoma. Detection and characterisation
by mouse monoclonal antibody. J. Exp. Med. 155,
1133-1147.
DOI
|